Nihon Medi-Physics Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Nihon Medi-Physics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer (NCT06129422) | Nihon Medi-Physics Co., Ltd. | 2023-10-31 |
Track Nihon Medi-Physics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.